Search research articles
Contact Us
Filters
Showing results (1-10 of 19) with videos related to
Page
of 2
Sort By:
Antimicrobial Agents and Chemotherapy
|
December 1, 1973
In vitro effect of virazole against influenza viruses
Y Togo
The Journal of Infectious Diseases
|
June 1, 1976
Double-blind clinical assessment of ribavirin (virazole) in the prevention of induced infection with type B influenza virus
Y Togo, E A McCracken
Journal of Medical Virology
|
January 1, 1977
Clinical and serologic effects of live attenuated serum inhibitor-resistant influenza B vaccine in seronegative adults
L W Miller, Y Togo, R B Hornick
Medical Microbiology and Immunology
|
May 18, 1977
Clinical evaluation of prophylactic intranasal 1-phenyl-3-(4-phenyl-2-thiazolyl) guanidine (CL 88,277) medication against rhinovirus 44 challenge
Y Togo, F E Durr, D A Laurenzana
Medical Microbiology and Immunology
|
December 30, 1975
Clinical and serologic effects of Alice strain live attenuated influenza A (H3N2) virus vaccine in an adult population
L W Miller, Y Togo, R B Hornick
Antimicrobial Agents and Chemotherapy
|
December 1, 1973
Antiviral effect of 3, 4-dihydro-1-isoquinolineacetamide hydrochloride in experimental human rhinovirus infection
Y Togo, A R Schwartz, R B Hornick
Hinyokika Kiyo. Acta Urologica Japonica
|
February 24, 2001
[A case of peripelvic extravasation related to pregnancy]
K Nakanishi, T Machida, T Toyoshima, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
September 1, 1991
First pass metabolism and in vitro metabolism of a new orally active dopamine prodrug, N-(N-acetyl-L-methionyl)-O,O-bis(ethoxycarbonyl)dopamine in dogs
M Yoshikawa, S Nishiyama, H Endo, et al.
The Journal of Infectious Diseases
|
June 1, 1976
Comparative clinical and laboratory evaluation of the prophylactic capacity of ribavirin, amantadine hydrochloride, and placebo in induced human influenza type A
A Cohen, Y Togo, R Khakoo, et al.
Infection and Immunity
|
January 1, 1973
Low-Temperature-Adapted Influenza A2/AA/6/60 Virus Vaccine in Man
T Kitayama, Y Togo, R B Hornick, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 19) with videos related to
Sort By:
Page
of 2
Antimicrobial Agents and Chemotherapy
|
December 1, 1973
In vitro effect of virazole against influenza viruses
Y Togo
The Journal of Infectious Diseases
|
June 1, 1976
Double-blind clinical assessment of ribavirin (virazole) in the prevention of induced infection with type B influenza virus
Y Togo, E A McCracken
Journal of Medical Virology
|
January 1, 1977
Clinical and serologic effects of live attenuated serum inhibitor-resistant influenza B vaccine in seronegative adults
L W Miller, Y Togo, R B Hornick
Medical Microbiology and Immunology
|
May 18, 1977
Clinical evaluation of prophylactic intranasal 1-phenyl-3-(4-phenyl-2-thiazolyl) guanidine (CL 88,277) medication against rhinovirus 44 challenge
Y Togo, F E Durr, D A Laurenzana
Medical Microbiology and Immunology
|
December 30, 1975
Clinical and serologic effects of Alice strain live attenuated influenza A (H3N2) virus vaccine in an adult population
L W Miller, Y Togo, R B Hornick
Antimicrobial Agents and Chemotherapy
|
December 1, 1973
Antiviral effect of 3, 4-dihydro-1-isoquinolineacetamide hydrochloride in experimental human rhinovirus infection
Y Togo, A R Schwartz, R B Hornick
Hinyokika Kiyo. Acta Urologica Japonica
|
February 24, 2001
[A case of peripelvic extravasation related to pregnancy]
K Nakanishi, T Machida, T Toyoshima, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
September 1, 1991
First pass metabolism and in vitro metabolism of a new orally active dopamine prodrug, N-(N-acetyl-L-methionyl)-O,O-bis(ethoxycarbonyl)dopamine in dogs
M Yoshikawa, S Nishiyama, H Endo, et al.
The Journal of Infectious Diseases
|
June 1, 1976
Comparative clinical and laboratory evaluation of the prophylactic capacity of ribavirin, amantadine hydrochloride, and placebo in induced human influenza type A
A Cohen, Y Togo, R Khakoo, et al.
Infection and Immunity
|
January 1, 1973
Low-Temperature-Adapted Influenza A2/AA/6/60 Virus Vaccine in Man
T Kitayama, Y Togo, R B Hornick, et al.
Page
of 2